As was the case for the plasma levels of both p-tau217 and total tau (Figure 9c,d), the effects of TEMT on the CSF oligomeric Aβ levels were dependent on the baseline levels in individual AD subjects. This evidence concerns the gene MAPT and Alzheimer disease.